Find uplifting stories about heroes, innovations, and solutions
14 results for "dmt"
Scientists discovered that a single dose of the psychedelic compound DMT produces longer-lasting antidepressant effects in mice than the currently approved rapid-acting treatment S-ketamine. This breakthrough could offer new hope for millions struggling with treatment-resistant depression.
A groundbreaking clinical trial shows one dose of the psychedelic DMT significantly reduced depression symptoms for up to six months. For millions who haven't found relief from traditional treatments, this research opens a promising new door.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
A groundbreaking trial in London shows that DMT, the shortest-acting psychedelic drug, helped nearly half of depression patients feel better within just one week. The fast-acting treatment could transform care by letting patients go home hours after treatment instead of days.
A clinical trial found that one dose of DMT, a natural psychedelic compound, significantly reduced depression symptoms for up to three months. The short treatment session could make mental health care more accessible for millions who don't respond to traditional antidepressants.
A groundbreaking trial in the UK found that a single dose of DMT paired with therapy rapidly reduced depression symptoms in patients, with improvements lasting at least three months. Nearly half the participants achieved remission, opening new hope for faster, more accessible mental health treatment.
Brazilian scientists discovered that one dose of the psychedelic DMT reversed depression symptoms in stressed mice better than 30 days of daily antidepressants. The breakthrough could lead to faster-acting treatments for severe depression.
A single dose of DMT, a natural compound in ayahuasca, rapidly reduced depression symptoms in a clinical trial and kept working for weeks. Scientists say the fast-acting treatment could help millions for whom current medications don't work.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F1b%2Fd1%2F1bd13e5f-b965-47b7-85a7-c1e653cecb61%2Ftobacco.jpg)
Researchers engineered tobacco plants to produce five therapeutic psychedelics, making it easier to study treatments for depression and PTSD. The breakthrough could replace harmful harvesting practices with sustainable medicine production.
A Tibetan lama with 54,000 hours of meditation experience showed identical brain patterns during deep meditation and a low dose of psychedelics. The discovery could help scientists understand consciousness and make meditation benefits more accessible.
Researchers engineered a single tobacco plant to produce five therapeutic psychedelic compounds, creating a sustainable alternative to harvesting endangered toads and mushrooms. This biological factory could revolutionize mental health treatment access.
Scientists analyzed over 500 brain scans and discovered that five different psychedelic drugs create remarkably similar patterns of brain activity. This breakthrough could speed up the development of new mental health treatments for depression, anxiety, and addiction.
Researchers analyzed over 500 brain scans and discovered a common "neural fingerprint" across LSD, psilocybin, and three other psychedelics. This breakthrough could strengthen clinical trials testing these substances for depression and PTSD.
A new medicine derived from LSD just passed two major clinical trials for treating anxiety and depression, offering hope for millions who need faster-acting mental health treatment. The drug showed benefits in as little as two days, unlike current medications that take weeks to work.